Filing Details
- Accession Number:
- 0001144204-18-029798
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-18 15:32:24
- Reporting Period:
- 2018-05-17
- Accepted Time:
- 2018-05-18 15:32:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1208261 | Immune Pharmaceuticals Inc | IMNP | Pharmaceutical Preparations (2834) | 521841431 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1608901 | S. Anthony Fiorino | C/O Immune Pharmaceuticals Inc. 550 Sylvan Avenue, Suite 101 Englewood Cliffs NJ 07632 | Chief Medical Officer And Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-17 | 50,000 | $0.26 | 50,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
